M. Miles Braun

11.5k total citations · 1 hit paper
79 papers, 8.1k citations indexed

About

M. Miles Braun is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, M. Miles Braun has authored 79 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 23 papers in Health and 20 papers in Infectious Diseases. Recurrent topics in M. Miles Braun's work include Vaccine Coverage and Hesitancy (23 papers), Influenza Virus Research Studies (15 papers) and Pneumonia and Respiratory Infections (9 papers). M. Miles Braun is often cited by papers focused on Vaccine Coverage and Hesitancy (23 papers), Influenza Virus Research Studies (15 papers) and Pneumonia and Respiratory Infections (9 papers). M. Miles Braun collaborates with scholars based in United States, Netherlands and Sweden. M. Miles Braun's co-authors include Sharon K. Gershon, Jeffrey Siegel, Robert P. Wise, William D. Schwieterman, Joseph Keane, John Kasznica, Evelyne T. Edwards, Robert Ball, S Brown and Robert T. Chen and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

M. Miles Braun

74 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

2001 2.7k citations Joseph Keane, Sharon K. Gershon et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by M. Miles Braun

Since Specialization

Citations

This map shows the geographic impact of M. Miles Braun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Miles Braun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Miles Braun more than expected).

Fields of papers citing papers by M. Miles Braun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Miles Braun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Miles Braun. The network helps show where M. Miles Braun may publish in the future.

Co-authorship network of co-authors of M. Miles Braun

This figure shows the co-authorship network connecting the top 25 collaborators of M. Miles Braun. A scholar is included among the top collaborators of M. Miles Braun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Miles Braun. M. Miles Braun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Temporary Practice Pause Then Resumption (TPPR) Study Design: An Extension of the Withdrawal Study Design to Complementary and Alternative Medicine Mind and Body Interventions (CAM-MABI) 2013 ·The Journal of Alternative and Complementary Medicine ·M. Miles Braun	2
2	Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years 2010 ·Nature Reviews Drug Discovery ·M. Miles Braun, (unknown), Kui Xu, Timothy R. Coté	107
3	Evaluation of Guillain-Barré Syndrome Among Recipients of Influenza Vaccine in 2000 and 2001 2010 ·American Journal of Preventive Medicine ·Dale R. Burwen, Robert Ball, Wilson W. Bryan, Héctor S. Izurieta, Lawrence La Voie, (unknown), (unknown), M. Miles Braun	42
4	Active Influenza Vaccine Safety Surveillance 2009 ·Medical Care ·Jeffrey S. Brown, (unknown), M. Miles Braun, Najat J. Ziyadeh, K. Arnold Chan, Grace M. Lee, Martin Kulldorff, Alexander M. Walker, Richard Platt	19
5	Monitorización de la invaginación tras la autorización de la vacuna RotaTeq en Estados Unidos, 1-2-2006/25-9-2007 2008 ·PEDIATRICS ·Penina Haber, Mansi Patel, Héctor S. Izurieta, James Baggs, Paul Gargiullo, Eric Weintraub, Margaret M. Cortese, M. Miles Braun, Edward A. Belongia, Elaine R. Miller, Robert Ball, (unknown), Umesh D. Parashar	1
6	Effects of Stratification on Data Mining in the US Vaccine Adverse Event Reporting System (VAERS) 2008 ·Drug Safety ·Emily Jane Woo, Robert Ball, Dale R. Burwen, M. Miles Braun	41
7	Kostenanalyse einer Knochenbank 2008 ·Zeitschrift für Orthopädie und ihre Grenzgebiete ·(unknown), M. Miles Braun	2
8	Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: Case definition and guidelines for data collection, analysis, and presentation 2007 ·Vaccine ·Michael Buettcher, Ulrich Heininger, M. Miles Braun, Jan Bonhoeffer, Scott A. Halperin, Harald Heijbel, Reinaldo de Menezes Martins, (unknown)	30
9	Inactivated influenza vaccine (IIV) in children <2 years of age: Examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine 2007 ·Vaccine ·Ann McMahon, John K. Iskander, Penina Haber, M. Miles Braun, Robert Ball	23
10	Confirmation of administrative claims‐identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor α antagonists and disease‐modifying antirheumatic drugs 2007 ·Arthritis Care & Research ·Jeffrey R. Curtis, Carolyn Martin, Kenneth G. Saag, Nivedita M. Patkar, Julia Krämer, Deborah Shatin, Jeroan J. Allison, M. Miles Braun	22
11	Evaluating adverse events after vaccination in the Medicare population 2007 ·Pharmacoepidemiology and Drug Safety ·Dale R. Burwen, Lawrence La Voie, M. Miles Braun, Peter M. Houck, Robert Ball	31
12	Comparing data mining methods on the VAERS database 2005 ·Pharmacoepidemiology and Drug Safety ·David Banks, Emily Jane Woo, Dale R. Burwen, (unknown), M. Miles Braun, Robert Ball	65
13	Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases 2005 ·Journal of the American Academy of Dermatology ·Timothy R. Coté, Aparna Mohan, Jacquelyn A. Polder, Marc K. Walton, M. Miles Braun	242
14	Tuberculosis following the Use of Etanercept, a Tumor Necrosis Factor Inhibitor 2004 ·Clinical Infectious Diseases ·(unknown), (unknown), Joel A. Block, Augustine Manadan, Jeffrey Siegel, M. Miles Braun	232
15	Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor α–neutralizing agents 2003 ·Arthritis & Rheumatism ·Nancy R. Slifman, Sharon K. Gershon, Jong‐Hoon Lee, Evelyne T. Edwards, M. Miles Braun	283
16	Adverse event reporting rates following tetanus–diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991–1997 2003 ·Vaccine ·(unknown), Penina Haber, Gina T. Mootrey, M. Miles Braun, Philip Rhodes, Robert T. Chen	23
17	Monitoring the Safety of Vaccines 2002 ·Drug Safety ·Susan S. Ellenberg, M. Miles Braun	45
18	Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent breakdown → 2001 ·New England Journal of Medicine ·Joseph Keane, Sharon K. Gershon, Robert P. Wise, (unknown), John Kasznica, William D. Schwieterman, Jeffrey Siegel, M. Miles Braun	2706
19	Heredity and prostate cancer: A study of World War II veteran twins 1997 ·The Prostate ·William F. Page, M. Miles Braun, Alan W. Partin, Neil E. Caporaso, Patrick Walsh	120
20	Descriptive epidemiology of adverse events after immunization: Reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994 1997 ·The Journal of Pediatrics ·M. Miles Braun, Susan S. Ellenberg	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact